In addition, recent studies suggest the potential roles of EGFR-mediated signaling in regulation of expression of the checkpoint molecule, PD-L1, in tumor cells, although the correlation between mutant EGFR status and PD-L1 expression in tumor tissues has been inconclusive. Here, CD274 is linked to neoplasm.